Effect of Mycobacterium butyricum on the hepatic cytochrome P-450 system of the mouse: Influence of anti-inflammatory drug

This publication has 11 references indexed in Scilit:

• Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor
  Published by Elsevier ,2004
• Prostaglandins: A possible mediator to inhibit hepatic drug metabolism in adjuvant arthritic rats
  Biochemical Medicine and Metabolic Biology, 1986
• The role of lymphocytes, macrophages and interferon in the depression of drug metabolism by dextran sulfate
  Immunopharmacology, 1986
• Regulation of macrophage collagenase, prostaglandin, and fibroblast-activating-factor production by anti-inflammatory agents: Different regulatory mechanisms for tissue injury and repair
  Cellular Immunology, 1985
• Inhibition of hepatic drug metabolism in the rat after Corynebacterium parvum treatment
  Biochemical Pharmacology, 1983
• Role of mononuclear phagocytes in decreased hepatic drug metabolism following administration of Corynebacterium parvum
  International Journal of Immunopharmacology, 1979
• Drug metabolism by microsomes from extrahepatic organs of rat and rabbit prepared by calcium aggregation
  Life Sciences, 1975
• A comparative study of two procedures used in the determination of hepatic microsomal aniline hydroxylation
  Toxicology and Applied Pharmacology, 1972
• BENZPYRENE HYDROXYLASE ACTIVITY IN ISOLATED PARENCHYMAL AND NONPARENCHYMAL CELLS OF RAT LIVER
  The Journal of cell biology, 1972
• Evidence for Biochemically Different Types of Vesicles in the Hepatic Microsomal Fraction*
  The Journal of Biochemistry, 1966